In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

A new study has found that users of Ozempic or a similar drug had a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than those without a prescription. Fernanda ...

According to a 2023 study published in The Lancet Rheumatology, nearly 1 billion people worldwide will be affected by the most common form of arthritis: osteoarthritis. Currently, the condition ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

Semaglutide medications — such as Ozempic, the popular diabetes drug — have been linked to a reduced risk of Alzheimer’s disease for certain groups. A new study, which was led by researchers ...

Ozempic was developed to treat type 2 diabetes, while Wegovy is FDA-approved for weight loss. In a series of trials published in Drug Design, Development and Therapy, participants who took 2.4 mg ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

Ozempic and related weight loss drugs may help people struggling with addiction, as they've been linked to a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol ...

The following table highlights the dosage and how you’ll take Ozempic and Wegovy for the conditions they both treat. All strengths are listed in milligrams per milliliter (mg/mL). To learn more ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Among these, the concept of "Nature's Ozempic" has emerged ... The capsules from Nature's Bounty each contain 100 mg of 5-HTP ...